van den Hoogen MW - Search Results

1

Effect of a single intraoperative high-dose ATG-Fresenius on delayed graft function in donation after cardiac-death donor renal allograft recipients: a randomized study.

van den Hoogen MW, Kho MM, Abrahams AC, van Zuilen AD, Sanders JS, van Dijk M, Hilbrands LB, Weimar W, Hoitsma AJ. van den Hoogen MW, et al. Among authors: van zuilen ad, van dijk m. Exp Clin Transplant. 2013 Apr;11(2):134-41. doi: 10.6002/ect.2012.0220. Epub 2013 Feb 22. Exp Clin Transplant. 2013. PMID: 23431996 Free article. Clinical Trial.

2

Treatment of steroid-resistant acute renal allograft rejection with alemtuzumab.

van den Hoogen MW, Hesselink DA, van Son WJ, Weimar W, Hilbrands LB. van den Hoogen MW, et al. Among authors: van son wj. Am J Transplant. 2013 Jan;13(1):192-6. doi: 10.1111/j.1600-6143.2012.04328.x. Epub 2012 Nov 21. Am J Transplant. 2013. PMID: 23167538 Free article.

3

Use of monoclonal antibodies in renal transplantation.

van den Hoogen MW, Hilbrands LB. van den Hoogen MW, et al. Immunotherapy. 2011 Jul;3(7):871-80. doi: 10.2217/imt.11.72. Immunotherapy. 2011. PMID: 21751955 Review.

4

Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.

van den Hoogen MW, Hoitsma AJ, Hilbrands LB. van den Hoogen MW, et al. Expert Opin Biol Ther. 2012 Aug;12(8):1031-42. doi: 10.1517/14712598.2012.689278. Epub 2012 May 15. Expert Opin Biol Ther. 2012. PMID: 22583145 Review.

5

Insulin requirement after a renal transplant in patients with type 2 diabetes: the choice of calcineurin inhibitors.

van den Hoogen MW, van der Hoeven AM, Hilbrands LB. van den Hoogen MW, et al. Among authors: van der hoeven am. Exp Clin Transplant. 2013 Jun;11(3):234-8. doi: 10.6002/ect.2012.0221. Epub 2013 Feb 22. Exp Clin Transplant. 2013. PMID: 23432070 Free article.

6

Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.

Kamburova EG, Koenen HJ, van den Hoogen MW, Baas MC, Joosten I, Hilbrands LB. Kamburova EG, et al. Among authors: van den hoogen mw. PLoS One. 2014 Nov 13;9(11):e112658. doi: 10.1371/journal.pone.0112658. eCollection 2014. PLoS One. 2014. PMID: 25393622 Free PMC article. Clinical Trial.

7

Cytokine Release After Treatment With Rituximab in Renal Transplant Recipients.

Kamburova EG, van den Hoogen MW, Koenen HJ, Baas MC, Hilbrands LB, Joosten I. Kamburova EG, et al. Among authors: van den hoogen mw. Transplantation. 2015 Sep;99(9):1907-11. doi: 10.1097/TP.0000000000000515. Transplantation. 2015. PMID: 25675201 Clinical Trial.

8

Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety.

van den Hoogen MW, Kamburova EG, Baas MC, Steenbergen EJ, Florquin S, M Koenen HJ, Joosten I, Hilbrands LB. van den Hoogen MW, et al. Am J Transplant. 2015 Feb;15(2):407-16. doi: 10.1111/ajt.13052. Am J Transplant. 2015. PMID: 25612493 Free article. Clinical Trial.

9

Idiopathic giant oesophageal ulcer and leucopoenia after renal transplantation.

van Boekel GA, Volbeda M, van den Hoogen MW, Hilbrands LB, Berden JH. van Boekel GA, et al. Among authors: van den hoogen mw. Neth J Med. 2012 Oct;70(8):370-3. Neth J Med. 2012. PMID: 23065985 Free article.

10

Anti-B cell therapy with rituximab as induction therapy in renal transplantation.

Joosten I, Baas MC, Kamburova EG, van den Hoogen MW, Koenen HJ, Hilbrands LB. Joosten I, et al. Among authors: van den hoogen mw. Transpl Immunol. 2014 Oct;31(4):207-9. doi: 10.1016/j.trim.2014.09.011. Epub 2014 Sep 28. Transpl Immunol. 2014. PMID: 25270152 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page